Identification and synthesis of substituted pyrrolo[2,3-d]pyrimidines as novel firefly luciferase inhibitors

被引：19

作者：

Liu, Yang ^{[1
]}

Fang, Jianping ^{[2
]}

Cai, Haiyan ^{[3
]}

Xiao, Fei ^{[2
]}

Ding, Kan ^{[2
]}

Hu, Youhong ^{[1
]}

机构：

[1] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China

[2] Chinese Acad Sci, Shanghai Inst Mat Med, Glycochem & Glycobiol Lab, Shanghai 201203, Peoples R China

[3] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2012年 / 20卷 / 18期

关键词：

Luciferase; Inhibitor; Pyrrolo[2,3-d]pyrimidine; High-throughput screening; Molecular docking; BINDING; ASSAYS;

D O I：

10.1016/j.bmc.2012.07.035

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A novel firefly luciferase inhibitor (3a) with a pyrrolo[2,3-d] pyrimidine core was identified in a cell-based NF-kappa B luciferase reporter gene assay. It potently inhibited the firefly luciferase derived from Photinus pyralis with an IC50 value of 0.36 +/- 0.05 mu M. Kinetic analysis of 3a inhibition showed that it is predominantly competitive with respect to D-luciferin and uncompetitive with respect to ATP. Therefore, several pyrrolo[2,3-d] pyrimidine analogues were prepared to further investigate the structure-activity relationship (SAR) for luciferase inhibition. The most potent inhibitor of this series was 4c, which showed an IC50 value of 0.06 +/- 0.01 mu M. In addition, molecular docking studies suggested that both 3a and 4c could be accommodated in the D-luciferin binding pocket, which is expected for a predominantly competitive inhibitor with respect to D-luciferin. (C) 2012 Elsevier Ltd. All rights reserved.

引用

页码：5473 / 5482

页数：10

共 50 条

[41] Synthesis of Some New Pyrimidines and Pyrrolo [2,3-d] Pyrimidines as Potential Antimicrobial Agents
Nofal, Z. M.
Fahmy, H. H.
Zarie, E. S.
Hamdy, A. A.
EGYPTIAN JOURNAL OF CHEMISTRY, 2011, 54 (05): : 595 - 608
[42] Substituted pyrrolo[2,3-d]pyrimidines as water soluble microtubule targeting agents
Gangjee, Aleem
Lin, Lu
Mooberry, Susan L.
Hamel, Ernest
CANCER RESEARCH, 2012, 72
[43] Novel antitumor and radioprotective sulfonamides containing pyrrolo[2,3-d]pyrimidines
Ghorab, Moustafa M.
Noaman, Eman
Ismail, Magda M. F.
Heiba, Helmy I.
Ammar, Yousry A.
Sayed, Marwa Y.
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2006, 56 (06): : 405 - 413
[44] SYNTHESIS OF THIOPYRANO [2,3-D]PYRIMIDINES AND THIENO [2,3-D]PYRIMIDINES
SANTILLI, AA
SCOTESE, AC
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1977, 14 (03) : 361 - 365
[45] IMPROVED PROCEDURES FOR THE SYNTHESES OF PYRIDO[2,3-D]PYRIMIDINES AND PYRROLO[2,3-D]PYRIMIDINES, AND RIBOSIDES THEREOF
ITOH, T
MELIKOHANJANIAN, RG
ISHIKAWA, I
KAWAHARA, N
MIZUNO, Y
HONMA, Y
HOZUMI, M
OGURA, H
CHEMICAL & PHARMACEUTICAL BULLETIN, 1989, 37 (12) : 3184 - 3190
[46] Synthesis of a DNA-Encoded Library of Pyrrolo[2,3-d]pyrimidines
Park, Jun Hyung
Wang, Hee Myeong
Shin, Min Hyeon
Lim, Hyun-Suk
BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2021, 42 (04) : 691 - 698
[47] SYNTHESIS OF THIOPYRANO[2,3-D]PYRIMIDINES AND THIENO[2,3-D]PYRIMIDINES
ASSY, MG
ELKAFRAWY, A
HASSANIEN, MM
POLISH JOURNAL OF CHEMISTRY, 1995, 69 (06) : 887 - 891
[48] Identification of pyrrolo[2,3-d]pyrimidines as potent HCK and FLT3-ITD dual inhibitors
Koda, Yasuko
Kikuzato, Ko
Mikuni, Junko
Tanaka, Akiko
Yuki, Hitomi
Honma, Teruki
Tomabechi, Yuri
Kukimoto-Niino, Mutsuko
Shirouzu, Mikako
Shirai, Fumiyuki
Koyama, Hiroo
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (22) : 4994 - 4998
[49] Efficient Synthesis of (Arylethynyl)pyrrolo[2,3-d]pyrimidines by Stille Coupling
Bucevicius, Jonas
Tumkevicius, Sigitas
SYNLETT, 2015, 26 (06) : 810 - 814
[50] Solid-phase synthesis of tetrasubstituted pyrrolo[2,3-d]pyrimidines
Lee, Ji Hoon
Lim, Hyun-Suk
ORGANIC & BIOMOLECULAR CHEMISTRY, 2012, 10 (21) : 4229 - 4235

← 1 2 3 4 5 →